Snowden Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,755
Closed -$204K 1220
2024
Q4
$204K Buy
+2,755
New +$204K 0.01% 1146
2024
Q3
Sell
-3,702
Closed -$342K 1232
2024
Q2
$342K Buy
3,702
+588
+19% +$54.3K 0.01% 922
2024
Q1
$298K Sell
3,114
-16
-0.5% -$1.53K 0.01% 960
2023
Q4
$239K Sell
3,130
-2,414
-44% -$184K 0.01% 1014
2023
Q3
$384K Sell
5,544
-41,646
-88% -$2.89M 0.02% 762
2023
Q2
$4.45M Buy
47,190
+5,514
+13% +$520K 0.16% 173
2023
Q1
$3.45M Sell
41,676
-651
-2% -$53.9K 0.13% 197
2022
Q4
$3.16M Sell
42,327
-7,932
-16% -$592K 0.13% 195
2022
Q3
$4.15M Buy
50,259
+1,717
+4% +$142K 0.19% 137
2022
Q2
$4.62M Buy
48,542
+7,094
+17% +$674K 0.21% 125
2022
Q1
$4.88M Buy
41,448
+38,230
+1,188% +$4.5M 0.2% 140
2021
Q4
$416K Sell
3,218
-3,371
-51% -$436K 0.02% 489
2021
Q3
$746K Buy
6,589
+187
+3% +$21.2K 0.04% 432
2021
Q2
$663K Sell
6,402
-3,152
-33% -$326K 0.03% 463
2021
Q1
$799K Buy
9,554
+55
+0.6% +$4.6K 0.05% 388
2020
Q4
$867K Sell
9,499
-286
-3% -$26.1K 0.06% 326
2020
Q3
$781K Buy
9,785
+2,705
+38% +$216K 0.06% 300
2020
Q2
$489K Sell
7,080
-3,531
-33% -$244K 0.04% 377
2020
Q1
$667K Buy
10,611
+6,153
+138% +$387K 0.07% 295
2019
Q4
$347K Sell
4,458
-60
-1% -$4.67K 0.03% 455
2019
Q3
$331K Sell
4,518
-60
-1% -$4.4K 0.03% 407
2019
Q2
$282K Sell
4,578
-396
-8% -$24.4K 0.03% 419
2019
Q1
$317K Sell
4,974
-2,871
-37% -$183K 0.03% 391
2018
Q4
$401K Buy
7,845
+234
+3% +$11.9K 0.05% 324
2018
Q3
$442K Buy
7,611
+2,730
+56% +$158K 0.05% 331
2018
Q2
$237K Sell
4,881
-18
-0.4% -$873 0.03% 395
2018
Q1
$228K Buy
+4,899
New +$228K 0.03% 351